Dilution of Share Value and Voting Rights from the Exercise of Stock Acquisition Rights
First written in FY2020. 14 of 17 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2026-H1.
rakumo moved to the "Worse" side of this theme in 2021, the same year as the typical company in this theme.
The whole theme swung hardest in 2017: 31 of 58 companies on the "Worse" side.
61 other companies' latest entry also says "Materialised".
- FY2026-H1MaterialisedAnnual report
「As of 23 April 2026, the total number of shares outstanding increased by 5,700 shares, while capital stock and capital surplus each increased by ¥2,983 thousand through the issuance of new shares as restricted stock compensation. This increase was due to the exercise of stock acquisition rights.」
During the interim period, 5,700 shares were issued as restricted stock compensation, and the number of shares outstanding increased by 3,500 shares through the exercise of stock acquisition rights. - FY2025MaterialisedAnnual report
「1 January 2025–31 December 2025 Common shares 19,900 Common shares 5,829,500」
The total number of shares outstanding increased by 19,900 shares during FY2025. This comprised 14,000 shares from the exercise of stock acquisition rights and 5,900 shares from restricted stock compensation, so the increase in shares associated with potential shares and stock-based compensation continued. The maximum dilution ratio disclosed was 24.58%. - FY2025-H1WorsenedAnnual report
「Class, details and number of shares underlying the stock acquisition rights (shares) Common shares 139,000」
The Company granted rights equivalent to 139,000 shares to directors and executive officers as Series 9 Stock Acquisition Rights, increasing its potential dilution exposure. In addition, 2,000 shares were added through the exercise of stock acquisition rights during the interim period. - FY2024MaterialisedAnnual report
「In May 2023, the Company issued Series 8 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights through a third-party allotment. If all Series 8 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights are exercised or converted, 1,432,700 new shares (14,327 voting rights) will be issued, resulting in a dilution ratio of 24.66% relative to the Company's 5,809,600 shares outstanding as of 31 December 2024 (58,058 voting rights), with the dilution ratio based on total voting rights being 24.68%.」
During 2024, the number of shares outstanding increased by 36,400 shares through the exercise of stock acquisition rights and other transactions, and the Company disclosed a 24.66% dilution ratio assuming the full exercise or conversion of the potential shares. - FY2024-H1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of shares outstanding increased by 8,400 shares through the exercise of stock acquisition rights between January and June 2024, and events that could lead to dilution continued to occur. - FY2024-Q1MaterialisedAnnual report
「Change in total shares outstanding (shares) 4,900」
The total number of shares outstanding increased by 4,900 shares through the exercise of stock acquisition rights between January and March 2024, and events that could lead to dilution continued to occur. - FY2023-Q3MaterialisedAnnual report
「The total number of shares outstanding was 5,766,200. If all Series 8 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights are exercised or converted, 1,432,700 new shares (14,327 voting rights) will be issued, resulting in a dilution ratio of 24.85% relative to the 5,766,200 shares outstanding as of 30 September 2023 (57,575 voting rights), with the dilution ratio based on total voting rights being 24.88%. This may cause changes in the supply-demand balance in the stock market and affect the share price.」
The maximum dilution ratio of 24.85% continues to be disclosed. In addition, 5,200 shares were added through the exercise of stock acquisition rights during the third quarter, and a further 3,500 shares were added after the end of the quarter, so events that could lead to dilution continued to occur. - FY2023-Q2WorsenedAnnual report
「The total number of shares outstanding was 5,761,000. If all Series 8 Stock Acquisition Rights and Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights are exercised or converted, 1,432,700 new shares (14,327 voting rights) will be issued, resulting in a dilution ratio of 24.87% relative to the 5,761,000 shares outstanding as of 30 June 2023 (57,575 voting rights), with the dilution ratio based on total voting rights being 24.88%.」
The potential for a 24.87% dilution ratio relative to the number of shares outstanding upon the full exercise or conversion of the stock acquisition rights and convertible bonds with stock acquisition rights has been newly specified. - FY2023-Q1MaterialisedAnnual report
「Between 1 April 2023 and 30 April 2023, the total number of shares outstanding increased by 1,400 shares through the exercise of stock acquisition rights.」
The number of shares outstanding also increased through the exercise of stock acquisition rights after the end of the quarter, and events that could lead to dilution continued to occur. - FY2022MaterialisedAnnual report
「1 January 2022–31 December 2022 Common shares 53,400 Common shares 5,748,900」
The total number of shares outstanding increased by 53,400 shares through the exercise of stock acquisition rights during 2022, and events that could lead to dilution continued to occur. - FY2022-Q3MaterialisedAnnual report
「Between 1 October 2022 and 31 October 2022, the total number of shares outstanding increased by 40,100 shares through the exercise of stock acquisition rights.」
In addition to the 2,400-share increase from the exercise of stock acquisition rights during the third quarter, the number increased by a further 40,100 shares in October 2022 before the filing date, and events that could lead to dilution continued to occur. - FY2022-Q2MaterialisedAnnual report
「Between 1 July 2022 and 31 July 2022, the total number of shares outstanding increased by 2,400 shares through the exercise of stock acquisition rights.」
The total number of shares outstanding also increased by 2,400 shares through the exercise of stock acquisition rights after the end of the quarter, and events that could lead to dilution continued to occur. - FY2022-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The total number of shares outstanding increased by 2,700 shares through the exercise of stock acquisition rights between January and March 2022, and events that could lead to dilution continued to occur. - FY2021MaterialisedAnnual report
「We grant stock acquisition rights as incentives to directors, executive officers and employees of our group. As of the end of the month preceding the month in which the annual securities report was filed, the number of potential shares represented 4.0% of the total number of shares issued.」
The potential dilution ratio fell from the previously stated 7.2% to 4.0%, while 175,100 shares increased during 2021 through the exercise of stock options and other instruments, and events that could lead to dilution continued to occur. - FY2021-Q3MaterialisedAnnual report
「Between 1 October 2021 and 31 October 2021, the total number of shares issued increased by 51,800 through the exercise of stock acquisition rights.」
The total number of shares issued increased further through the exercise of stock acquisition rights, creating an event that could lead to the dilution of existing shareholders' share value and voting rights. - FY2021-Q1MaterialisedAnnual report
「Between 1 April 2021 and 30 April 2021, the total number of shares issued increased by 66,700 through the exercise of stock acquisition rights.」
The number of shares issued actually increased through the exercise of stock acquisition rights, creating an event that could lead to the dilution of existing shareholders' share value and voting rights, as previously disclosed. - FY2020First statedAnnual report
「We grant stock acquisition rights as incentives to directors, executive officers and employees of our group. As of the end of the month preceding the month in which the annual securities report was filed, the number of potential shares represented 7.2% of the total number of shares issued. If these stock acquisition rights are exercised, new shares will be issued, potentially diluting the value of shares held by existing shareholders and their voting rights.」
The company discloses that potential shares represent 7.2% and explicitly identifies the possibility of dilution resulting from the exercise of stock acquisition rights.